Listed by the USPTO as KIEFER, DALTON EDWARD
Tech Center 1600 • Art Units: 1619 1652 1674
This examiner grants 86% of resolved cases
This examiner works in Tech Center 1600 and Art Unit 1619, with 7 resolved cases. The allowance rate is 85.7%, while the median time to allowance is 1132 days. The small resolved-case record makes the allowance and timing measures preliminary indicators rather than a settled basis for predicting an individual application.
The interview lift is 16.7%, suggesting that interviews may contribute useful value in prosecution before this examiner. Applicants should treat the result as directional because the underlying record is limited. The leading companies are CJ CheilJedang Corporation, Merck Patent GmbH, and Massachusetts Institute of Technology. The leading firms are ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM LLP, Barron & Young PLLC, and Bell & Manning, LLC.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025050 | A RECOMBINANT MICROORGANISM FOR PRODUCING L-GLUTAMIC ACID AND A METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME | Final Rejection | CJ CHEILJEDANG CORPORATION |
| 18708273 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | Non-Final OA | MERCK PATENT GMBH |
| 18932763 | PROGRAMMABLE NUCLEASE-PEPTIDASE COMPOSITIONS | Non-Final OA | Massachusetts Institute of Technology |
| 18572490 | POLYNUCLEOTIDES ENCODING URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1 FOR THE TREATMENT OF CRIGLER-NAJJAR SYNDROME | Non-Final OA | ModernaTX, Inc. |
| 18571882 | COMPOSITION WITH IMPROVED MOISTURE MANAGEMENT PERFORMANCE | Non-Final OA | HENKEL AG & CO. KGAA |
| 18724369 | POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18726607 | BIOSYNTHESIS OF HIERARCHICAL METAL ORGANIC FRAMEWORK-BACTERIAL CELLULOSE COMPOSITES | Non-Final OA | The Hong Kong Polytechnic University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy85.7% of resolved applications examined by Dalton Edward Kiefer were allowed (7 resolved cases), compared with 22.7% across Art Unit 1619 over the last five years.
This examiner's interview lift is +16.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Dalton Edward Kiefer took 1,132 days on average from filing to allowance.
Dalton Edward Kiefer examines applications in Art Unit 1619 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
